Fig. 3From: Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcomeSubgroup analysis of survival. Overall survival by tumor differentiation (A) (p = 0.003) and progression-free survival by downstaging T (B) (p = 0.027) in patients with unresectable LASCC with neoadjuvant chemoradiotherapy and surgeryBack to article page